A Phase I Study of an Anti-GD3 Monoclonal Antibody, KW-2871, in Patients with Metastatic Melanoma
Year: 2006
Type: article
Study design: Clinical Trial
Institution: University of Alabama at Birmingham
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2066442117
